FI96026B - Menetelmä terapeuttisesti tehokkaiden 4(5)-asemassa bisyklisellä ryhmällä substituoitujen imidatsolien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti tehokkaiden 4(5)-asemassa bisyklisellä ryhmällä substituoitujen imidatsolien valmistamiseksi

Info

Publication number
FI96026B
FI96026B FI895325A FI895325A FI96026B FI 96026 B FI96026 B FI 96026B FI 895325 A FI895325 A FI 895325A FI 895325 A FI895325 A FI 895325A FI 96026 B FI96026 B FI 96026B
Authority
FI
Finland
Prior art keywords
preparation
therapeutically effective
bicyclic group
hal
alkyl
Prior art date
Application number
FI895325A
Other languages
English (en)
Swedish (sv)
Other versions
FI895325A0 (fi
FI96026C (fi
Inventor
Arto Johannes Karjalainen
Raimo Einari Virtanen
Arja Leena Karjalainen
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of FI895325A0 publication Critical patent/FI895325A0/fi
Publication of FI96026B publication Critical patent/FI96026B/fi
Application granted granted Critical
Publication of FI96026C publication Critical patent/FI96026C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI895325A 1988-12-09 1989-11-09 Menetelmä terapeuttisesti tehokkaiden 4(5)-asemassa bisyklisellä ryhmällä substituoitujen imidatsolien valmistamiseksi FI96026C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8828831 1988-12-09
GB8828831A GB2225782A (en) 1988-12-09 1988-12-09 Imidazole derivatives useful for treatment of diabetes

Publications (3)

Publication Number Publication Date
FI895325A0 FI895325A0 (fi) 1989-11-09
FI96026B true FI96026B (fi) 1996-01-15
FI96026C FI96026C (fi) 1996-04-25

Family

ID=10648267

Family Applications (1)

Application Number Title Priority Date Filing Date
FI895325A FI96026C (fi) 1988-12-09 1989-11-09 Menetelmä terapeuttisesti tehokkaiden 4(5)-asemassa bisyklisellä ryhmällä substituoitujen imidatsolien valmistamiseksi

Country Status (22)

Country Link
US (1) US5292887A (fi)
EP (1) EP0372954B1 (fi)
JP (1) JP2868813B2 (fi)
KR (1) KR900009605A (fi)
CN (1) CN1023219C (fi)
AT (1) ATE102608T1 (fi)
AU (1) AU619928B2 (fi)
CA (1) CA2004799A1 (fi)
DD (1) DD290880A5 (fi)
DE (1) DE68913673T2 (fi)
DK (1) DK603789A (fi)
ES (1) ES2052937T3 (fi)
FI (1) FI96026C (fi)
GB (1) GB2225782A (fi)
HU (1) HU205086B (fi)
IE (1) IE61870B1 (fi)
IL (1) IL92609A0 (fi)
NO (1) NO177138C (fi)
NZ (1) NZ231649A (fi)
PT (1) PT92515B (fi)
RU (2) RU1831479C (fi)
ZA (1) ZA899366B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI862039A0 (fi) * 1986-05-15 1986-05-15 Farmos Oy Nytt foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat.
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9312669D0 (en) 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
FR2735776B1 (fr) * 1995-06-22 1997-07-18 Synthelabo Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
EP1147092A1 (en) * 1999-01-18 2001-10-24 Novo Nordisk A/S Substituted imidazoles, their preparation and use
US6388090B2 (en) 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
FI20000073A0 (fi) * 2000-01-14 2000-01-14 Orion Yhtymae Oy Uusia imidatsolijohdannaisia
PE20011321A1 (es) * 2000-05-08 2002-01-03 Orion Corp Indanilimizadoles policiclicos nuevos con actividad adrenergica alfa 2
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
FR2839719B1 (fr) * 2002-05-16 2004-08-06 Pf Medicament Nouveaux composes imidazoliques, leur procede de preparation et leur utilisation a titre de medicaments
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
FI81092C (fi) * 1986-05-15 1990-09-10 Farmos Oy Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.

Also Published As

Publication number Publication date
HU205086B (en) 1992-03-30
NO894563L (no) 1990-06-11
NO894563D0 (no) 1989-11-16
HUT52065A (en) 1990-06-28
NO177138B (no) 1995-04-18
AU4599289A (en) 1990-08-16
IE893926L (en) 1990-06-09
IL92609A0 (en) 1990-08-31
DE68913673T2 (de) 1994-07-14
CA2004799A1 (en) 1990-06-09
DK603789D0 (da) 1989-11-30
FI895325A0 (fi) 1989-11-09
IE61870B1 (en) 1994-11-30
ZA899366B (en) 1991-03-27
EP0372954A1 (en) 1990-06-13
PT92515A (pt) 1990-06-29
PT92515B (pt) 1995-08-09
DE68913673D1 (de) 1994-04-14
ES2052937T3 (es) 1994-07-16
EP0372954B1 (en) 1994-03-09
KR900009605A (ko) 1990-07-05
ATE102608T1 (de) 1994-03-15
NO177138C (no) 1995-07-26
GB2225782A (en) 1990-06-13
NZ231649A (en) 1991-09-25
DD290880A5 (de) 1991-06-13
CN1023219C (zh) 1993-12-22
CN1043128A (zh) 1990-06-20
FI96026C (fi) 1996-04-25
JPH02202874A (ja) 1990-08-10
DK603789A (da) 1990-06-10
RU1831479C (ru) 1993-07-30
AU619928B2 (en) 1992-02-06
US5292887A (en) 1994-03-08
JP2868813B2 (ja) 1999-03-10
GB8828831D0 (en) 1989-01-18
RU1833375C (en) 1993-08-07

Similar Documents

Publication Publication Date Title
ATE85050T1 (de) Substituierte imidazol-derivate und verfahren zu deren herstellung und deren anwendung.
DE3750443T2 (de) Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und antibakterielle Mittel.
FI96026B (fi) Menetelmä terapeuttisesti tehokkaiden 4(5)-asemassa bisyklisellä ryhmällä substituoitujen imidatsolien valmistamiseksi
DE3572170D1 (de) Quinolonecarboxylic acid derivatives
ES2046229T3 (es) Composicion antiulcerosa.
ES2063058T3 (es) N,n'-carbonil-bis-(4-etil-2,3-dioxo)-piperazina, proceso para su preparacion y uso de la misma.
PT78717B (de) Neue 1-acetonyl-2-(phenylimino)-imidazolidine deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
DE3675431D1 (de) 1,3-oxathianderivate.
GR3002688T3 (en) Thiadiazolylacetamide derivatives, process for the preparation thereof and their use
DE3772850D1 (de) Thiadiazinon-derivate.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: FARMOS-YHTYMAE OY